2025 Artificial Tears Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Artificial Tears Market Size By 2025?
The market for artificial tears has seen significant growth in the past few years. Its size is projected to increase from $3.55 billion in 2024 to $3.74 billion in 2025, counting a compound annual growth rate (CAGR) of 5.5%. The historic growth of this market has been influenced by factors such as the aging population, extended screen time, healthcare spending, transition from prescription to over-the-counter availability, and regulatory alterations.

How Big Is the Artificial Tears Market Size Expected to Grow by 2029?
The market size for artificial tears is anticipated to witness robust expansion in the coming years, reaching a figure of "$4.76 billion in 2029", expanding at a compound annual growth rate (CAGR) of 6.2%. The projected growth during the forecast period can be linked to the rising incidence of dry eye syndrome, the proliferation of contact lens wearers, worldwide urbanization, intensifying pollution, and the progression of e-commerce. Significant trends expected throughout the forecast period encompass technological progress, synergy between AI and tech, collaborations with healthcare service providers, incorporation of organic ingredients, advancements in the formulation of the product, state-of-the-art drug delivery mechanisms, and products that are sustainable and environmentally friendly.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

Which Key Market Drivers Powering Artificial Tears Market Expansion and Growth?
The growth of the artificial tear market is likely to be driven by the increasing occurrence of dry eye disease. Dry eye disease, a condition where the eyes fail to produce enough or quality tears, causing discomfort and irritation, can be treated with artificial tears which supplement natural tear production and give relief for dry eyes. For example, a March 2022 survey by Macquarie University, a public research university in Australia, with 5,000 participants revealed that 13% (15 out of 120) of individuals aged 50 and above exhibited clinical signs of dry eye disease (DED). The categories included 8.2% mild, 2.5% moderate, and 1.6% severe. Besides, Eyes On Eyecare, a digital ophthalmology news provider in the US, indicated in March 2022 that the application of prescription and in-clinic treatments for dry eye disease rose from 5.8% in 2021 to 7.56% in 2022. This includes a notable increase in the use of prescription treatments like topical steroids from 0.9% to 9.1% in the same period. Consequently, the escalating occurrence of dry eye disease is facilitating the growth of the artificial tear market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

What Are the Key Trends Driving Artificial Tears Market Growth?
Leading businesses within the artificial tears market are innovating their product line by incorporating new technologies such as patented pureflow technology to improve product safety and usability. The patented pureflow technology is a unique delivery system that uses a single-direction valve to ensure sterile dispensing of preservative-free eye drops, thereby averting contamination and preserving product integrity. For example, in January 2022, Alcon Inc., a health device and pharmaceutical company based in Switzerland, released Systane Complete Preservative-Free Lubricant Eye Drops. These superior artificial tears are specifically created to alleviate symptoms linked with various major dry eye conditions, like evaporative dry eye and aqueous tear deficiency. By being a preservative-free solution, they deliver up to eight hours of long-lasting relief by moisturizing and safeguarding every layer of the tear film. With the use of nano-droplet technology, the drops provide immediate hydration to the eye surface, inhibit tear evaporation, and ensure prompt, effective comfort. The product is available in a handy multi-dose bottle featuring PureFlow technology, guaranteeing safety by circumventing contamination, this making it ideal for regular users and those with sensitive eyes.

What Are the Emerging Segments in the Artificial Tears Market?
The artificial tears market covered in this report is segmented -

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears
2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray
3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications
4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:
1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears
2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears
3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears
4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears
5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears
6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13799&type=smp

Who Are the Global Leaders in the Artificial Tears Market?
Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Which are the Top Profitable Regional Markets for the Artificial Tears Industry?
North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13799

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.